Literature DB >> 26676033

Animal Models Used to Study Superantigen-Mediated Diseases.

Amanda J Brosnahan1.   

Abstract

Superantigens secreted by Staphylococcus aureus and Streptococcus pyogenes interact with the T-cell receptor and major histocompatibility class II molecules on antigen-presenting cells to elicit a massive cytokine release and activation of T cells in higher numbers than that seen with ordinary antigens. Because of this unique ability, superantigens have been implicated as etiological agents for many different types of diseases, including toxic shock syndrome, infective endocarditis, pneumonia, and inflammatory skin diseases. This review covers the main animal models that have been developed in order to identify the roles of superantigens in human disease.

Entities:  

Keywords:  Animal model; Atopic dermatitis; Emesis; Endocarditis; Pneumonia; Staphylococcus aureus; Streptococcus pyogenes; Superantigen; Toxic shock syndrome

Mesh:

Substances:

Year:  2016        PMID: 26676033     DOI: 10.1007/978-1-4939-3344-0_1

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  3 in total

1.  Systemic cytokine and chemokine responses in immunized mice challenged with staphylococcal enterotoxin B.

Authors:  Laura C Hudson Reichenberg; Renu Garg; Raymond Fernalld; Kenneth L Bost; Kenneth J Piller
Journal:  Toxicon       Date:  2017-05-03       Impact factor: 3.033

2.  "Small" Intestinal Immunopathology Plays a "Big" Role in Lethal Cytokine Release Syndrome, and Its Modulation by Interferon-γ, IL-17A, and a Janus Kinase Inhibitor.

Authors:  Shiv D Kale; Brittney N Mehrkens; Molly M Stegman; Bridget Kastelberg; Henry Carnes; Rachel J McNeill; Amy Rizzo; Saikumar V Karyala; Sheryl Coutermarsh-Ott; Jackie A Fretz; Ying Sun; Jonathan L Koff; Govindarajan Rajagopalan
Journal:  Front Immunol       Date:  2020-06-26       Impact factor: 7.561

3.  Are superantigens the cause of cytokine storm and viral sepsis in severe COVID-19? Observations and hypothesis.

Authors:  Valeria Scaglioni; Enrique R Soriano
Journal:  Scand J Immunol       Date:  2020-08-04       Impact factor: 3.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.